Home › Research › Caregiving
Burden and care time for dementia caregivers in the LIVE@Home.Path trial
Line Iden Berge, Renira C. Angeles, Marie Hidle Gedde, Stein Erik Fæø, Janne Mannseth, Maarja Vislapuu, Nathalie Genevieve Puaschitz, Eirin Hillestad et al.. Alzheimer s & Dementia, 2025-03-01
Topic: Risk, prevention and care in population studies
Plain-language summary
Two hundred eighty dyads were enrolled. Caregivers during the intervention period reported lower levels of RSS of 0.7 points (standard deviation [SD]: 0.8) compared to the caregivers in the control period. Caregivers during the intervention period reported more time spent on PADL of 11.7 hours/month (SD: 8.7) compared to caregivers during the control period; both were not statistically significant (P > 0.05). The LIVE intervention did not reduce caregiver burden or care time. TRIAL REGISTRATION: ClinicalTrials.gov NCT04043364. HIGHLIGHTS: Two hundred eighty persons with dementia and caregivers were included in a stepped wedge randomized controlled trial. We used the learning, innovation, volunteer support, empowerment (LIVE) intervention. The LIVE intervention did not reduce caregiver burden or informal care time. The LIVE intervention improved the caregiver's clinical global impression of change. Positive change was most pronounced for coordinator personalized support.
What this study adds
Evidence grade: High
This is a trial. In this randomized controlled trial, the LIVE intervention did not reduce caregiver burden or care time, with both differences not statistically significant. It did improve caregivers' clinical global impression of change, most notably for coordinator personalized support.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Berge, L. I., Angeles, R. C., Gedde, M. H., Fæø, S. E., Mannseth, J., Vislapuu, M., et al. (2025). Burden and care time for dementia caregivers in the LIVE@Home.Path trial. Alzheimer s & Dementia. https://doi.org/10.1002/alz.14622
Vancouver
Berge LI, Angeles RC, Gedde MH, Fæø SE, Mannseth J, Vislapuu M, et al. Burden and care time for dementia caregivers in the LIVE@Home.Path trial. Alzheimer s & Dementia. 2025. doi:10.1002/alz.14622. PMID: 40042468.
BibTeX
@article{berge2025-40042468,
author = {Berge, Line Iden and Angeles, Renira C. and Gedde, Marie Hidle and Fæø, Stein Erik and Mannseth, Janne and Vislapuu, Maarja and Puaschitz, Nathalie Genevieve and Hillestad, Eirin and others},
title = {{Burden and care time for dementia caregivers in the LIVE@Home.Path trial}},
journal = {Alzheimer s \& Dementia},
year = {2025},
doi = {10.1002/alz.14622},
pmid = {40042468},
url = {https://doi.org/10.1002/alz.14622}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- Caregivers during the intervention period reported lower levels of RSS of 0.7 points (standard deviation [SD]: 0.8) compared to the caregivers in the control period.
- Caregivers during the intervention period reported more time spent on PADL of 11.7 hours/month (SD: 8.7) compared to caregivers during the control period; both were not statistically significant (P > 0.05).
- The LIVE intervention did not reduce caregiver burden or care time.
- TRIAL REGISTRATION: ClinicalTrials.gov NCT04043364.
- HIGHLIGHTS: Two hundred eighty persons with dementia and caregivers were included in a stepped wedge randomized controlled trial.
Why it matters
In this randomized controlled trial, the LIVE intervention did not reduce caregiver burden or care time, with both differences not statistically significant. It did improve caregivers' clinical global impression of change, most notably for coordinator personalized support.
New to this subject? Start with our plain-English guide: Caregiving →
Study details
- Study designrandomized controlled trial
- Evidence strengthHigh
How this study scored 59/100
Published in a peer-reviewed journal, and it is a randomized controlled trial. Scored zero for sample size, effect reported and studied in people because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Alzheimer s & Dementia) |
| Journal's citation record | 2 / 4 | Alzheimer s & Dementia: journal h-index 228 (OpenAlex, 2026-10-29) |
| Study design | 11 / 12 | A randomized controlled trial |
| Strength of evidence | 5 / 5 | Rated “high” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 1 / 2 | Randomized (as stated in the record) |
| Times cited | 2 / 7 | Cited 6 times (OpenAlex, 2026-10-10) |
| Citations per year | 1 / 5 | 2.0 citations a year over 3 year(s) since 2025 |
| Impact for its field and year | 3 / 6 | Cited 3.8× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 1 / 4 | Cited 6 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 2 / 4 | Last-listed author Bettina Sandgathe Husebo: h-index 45 (OpenAlex, whole career) |
| Institution's track record | 3 / 3 | Harvard University: institution h-index 3,235 (OpenAlex) |
| Multicenter collaboration | 3 / 3 | OpenAlex lists 15 institution(s) in 4 countries |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 40042468) |
| Free to read | 2 / 2 | Free to read |
| Total | 59 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Related studies in Caregiving from nearby years
Also tagged “nursing”
995 studies in the library carry the topic tag “nursing”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 995 tagged studies.